$JAZZ
Jazz Pharmaceuticals PLC

2013 Q2 Form 10-Q Financial Statement

#000123252413000059 Filed on August 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $208.3M $124.2M
YoY Change 67.63% 92.41%
Cost Of Revenue $25.00M $12.30M
YoY Change 103.25% 261.76%
Gross Profit $181.5M $110.7M
YoY Change 63.97% 84.23%
Gross Profit Margin 87.17% 89.12%
Selling, General & Admin $77.51M $57.22M
YoY Change 35.44% 159.0%
% of Gross Profit 42.7% 51.69%
Research & Development $9.250M $2.321M
YoY Change 298.54% -31.37%
% of Gross Profit 5.1% 2.1%
Depreciation & Amortization $20.00M $16.00M
YoY Change 25.0% 742.11%
% of Gross Profit 11.02% 14.45%
Operating Expenses $131.2M $84.80M
YoY Change 54.69% 176.16%
Operating Profit $77.07M $39.43M
YoY Change 95.47% 16.44%
Interest Expense -$7.142M -$1.481M
YoY Change 382.24% 125.42%
% of Operating Profit -9.27% -3.76%
Other Income/Expense, Net
YoY Change
Pretax Income $65.79M $37.71M
YoY Change 74.48% 13.57%
Income Tax $23.61M $6.593M
% Of Pretax Income 35.88% 17.49%
Net Earnings $42.19M $27.15M
YoY Change 55.41% -18.24%
Net Earnings / Revenue 20.26% 21.85%
Basic Earnings Per Share $0.72 $0.48
Diluted Earnings Per Share $0.69 $0.45
COMMON SHARES
Basic Shares Outstanding 58.74M shares 56.95M shares
Diluted Shares Outstanding 61.57M shares 60.55M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $504.3M $154.5M
YoY Change 226.41% 50.88%
Cash & Equivalents $504.3M $154.5M
Short-Term Investments $504.0M $0.00
Other Short-Term Assets $19.72M $13.51M
YoY Change 45.96% 237.7%
Inventory $28.13M $48.36M
Prepaid Expenses $21.41M $5.906M
Receivables $114.1M $78.13M
Other Receivables $0.00 $0.00
Total Short-Term Assets $734.2M $300.4M
YoY Change 144.37% 120.75%
LONG-TERM ASSETS
Property, Plant & Equipment $10.77M $4.631M
YoY Change 132.52% 671.83%
Goodwill $439.0M $446.2M
YoY Change -1.62%
Intangibles $823.0M $927.4M
YoY Change -11.26%
Long-Term Investments
YoY Change
Other Assets $5.502M $19.23M
YoY Change -71.38% 9513.0%
Total Long-Term Assets $1.360B $1.398B
YoY Change -2.7% 2338.92%
TOTAL ASSETS
Total Short-Term Assets $734.2M $300.4M
Total Long-Term Assets $1.360B $1.398B
Total Assets $2.094B $1.698B
YoY Change 23.32% 777.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.37M $34.51M
YoY Change -40.97% 634.15%
Accrued Expenses $96.77M $125.1M
YoY Change -22.63% 368.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $5.572M $23.75M
YoY Change -76.54% -27.37%
Total Short-Term Liabilities $184.3M $192.3M
YoY Change -4.15% 136.55%
LONG-TERM LIABILITIES
Long-Term Debt $546.7M $444.2M
YoY Change 23.08%
Other Long-Term Liabilities $13.33M $1.615M
YoY Change 725.39% -84.62%
Total Long-Term Liabilities $560.1M $445.8M
YoY Change 25.63% 4145.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $184.3M $192.3M
Total Long-Term Liabilities $560.1M $445.8M
Total Liabilities $744.4M $638.1M
YoY Change 16.65% 595.12%
SHAREHOLDERS EQUITY
Retained Earnings -$29.26M -$295.1M
YoY Change -90.08%
Common Stock $1.185B $1.126B
YoY Change 5.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.175B $831.5M
YoY Change
Total Liabilities & Shareholders Equity $2.094B $1.698B
YoY Change 23.32% 777.94%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $42.19M $27.15M
YoY Change 55.41% -18.24%
Depreciation, Depletion And Amortization $20.00M $16.00M
YoY Change 25.0% 742.11%
Cash From Operating Activities $8.700M $77.00M
YoY Change -88.7% 105.33%
INVESTING ACTIVITIES
Capital Expenditures -$3.600M -$10.50M
YoY Change -65.71% 775.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$550.7M
YoY Change -100.0% -137775.0%
Cash From Investing Activities -$3.600M -$561.2M
YoY Change -99.36% 70050.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 47.50M 468.6M
YoY Change -89.86% 66842.86%
NET CHANGE
Cash From Operating Activities 8.700M 77.00M
Cash From Investing Activities -3.600M -561.2M
Cash From Financing Activities 47.50M 468.6M
Net Change In Cash 52.60M -15.60M
YoY Change -437.18% -141.71%
FREE CASH FLOW
Cash From Operating Activities $8.700M $77.00M
Capital Expenditures -$3.600M -$10.50M
Free Cash Flow $12.30M $87.50M
YoY Change -85.94% 126.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20367000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15887000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75480000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
114075000 USD
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
24900000 USD
CY2013Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
17739000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
104666000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96771000 USD
CY2013Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1660000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2163000 USD
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3271000 USD
CY2013Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3898000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7779000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8915000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19220000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
31046000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1184965000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1151010000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29264000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38954000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2596000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1522000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1079000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2839000 shares
CY2013Q2 us-gaap Assets
Assets
2093880000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-309000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
114000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1404000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1597000 USD
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
6380000 USD
CY2012Q4 us-gaap Assets
Assets
1966493000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
551572000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
734176000 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
387196000 USD
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
504307000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
504307000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
387196000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7900000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-200000 USD
CY2013Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0 USD
CY2012Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
34800000 USD
CY2013Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
5371000 USD
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4292000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
504307000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
387196000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154543000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82076000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
117111000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
72467000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54469000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73784000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26754000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50799000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash equivalents and marketable securities. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and marketable securities and issuers of investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to hospitals, pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the United States, and to other international distributors. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse effect on our financial position, liquidity or results of operations. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">87%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts Specialty Distribution Services, Inc. and its affiliate CuraScript, Inc., or Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">70%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Accredo Health Group, Inc., or Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160;As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">78%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">51%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">11%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We depend on single source suppliers and manufacturers for each of our products, product candidates and their active pharmaceutical ingredients.</font></div></div>
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1135000 USD
CY2013Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4204000 USD
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1049000 USD
CY2013Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1049000 USD
CY2012Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
16576000 USD
CY2013Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
16308000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9064000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6776000 USD
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6283000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
35813000 USD
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
46538000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
65136000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
74850000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
259000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
275000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
178393000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
167744000 USD
us-gaap Depreciation
Depreciation
1170000 USD
us-gaap Depreciation
Depreciation
415000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-6522000 USD
CY2012Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-3968000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
5308000 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
11192000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-491000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2077000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.165
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.175
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.325
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
6238000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
6238000 USD
CY2013Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2012Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
99632000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
137886000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
467073000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
38828000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
66998000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
67090000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
71419000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
77459000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
926753000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
933434000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
788867000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
833802000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1953000 USD
CY2013Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1934000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-40000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-139000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
442600000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
439014000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
6709000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-3586000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
42185000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
61348000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
85610000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
31113000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37706000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126849000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73458000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65790000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.55
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.11
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.72
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.46
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.51
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.39
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.69
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.03
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3968000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-6522000 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.12
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.11
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6593000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12110000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41239000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23605000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4707000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11363000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7427000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39015000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-21898000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5568000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10771000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7749000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-492000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
250000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6104000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-789000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-837000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
354000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2617000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14672000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5390000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1537000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2162000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2249000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1417000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1414000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1633000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1440000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1456000 shares
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
969584000 USD
CY2013Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
960862000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
869952000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
822976000 USD
CY2012Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1481000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14541000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1450000 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7142000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16136000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14846000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
28130000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
26525000 USD
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6090000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4979000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5410000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7194000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3899000 USD
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3980000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2093880000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1966493000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
184346000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
191538000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5572000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29688000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
427073000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
546724000 USD
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
78000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
94000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
450428000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50589000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6010000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-478734000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74609000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101264000 USD
us-gaap Net Income Loss
NetIncomeLoss
85610000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
27145000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
42185000 USD
us-gaap Net Income Loss
NetIncomeLoss
54826000 USD
CY2013Q2 us-gaap Noncurrent Assets
NoncurrentAssets
10768000 USD
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
7281000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Expenses
OperatingExpenses
259236000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
131186000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
84804000 USD
us-gaap Operating Expenses
OperatingExpenses
151595000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
145253000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
75166000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
77066000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
39427000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
28700000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4300000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2599000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4942000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7988000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8714000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
157000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17636000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18712000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19113000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
19716000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3662000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5502000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-388000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-388000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8614000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11826000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-391000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-357000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11826000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8614000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-17000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-23000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6621000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13330000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3251000 USD
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
385000 USD
CY2012Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
240000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
258000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25299000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
37443000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
542531000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1300000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2494000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4710000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7445000 USD
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21410000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
450916000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
553425000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
31988000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
81246000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19683000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15060000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7281000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10768000 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
3687000 USD
CY2013Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
4116000 USD
CY2013Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
500000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
463124000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6280000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9250000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19997000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2321000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
1227000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
1280000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61296000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29264000 USD
us-gaap Revenues
Revenues
404489000 USD
us-gaap Revenues
Revenues
226761000 USD
CY2012Q2 us-gaap Revenues
Revenues
124231000 USD
CY2013Q2 us-gaap Revenues
Revenues
208252000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
401216000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
224454000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
206564000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
123002000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101580000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
148034000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57224000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77506000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20263000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8539000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-53578000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
1175453000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1121292000 USD
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
39884000 USD
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
17539000 USD
CY2013Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
34500000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59319000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60554000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61541000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61568000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56952000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58548000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58737000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55437000 shares
CY2013Q2 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
31799000 USD
CY2012Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
29235000 USD
CY2013Q2 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2012Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2012Q4 jazz Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
0 USD
CY2013Q2 jazz Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
42700000 USD
CY2012Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnology
12289000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnology
52251000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnology
20033000 USD
CY2013Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnology
25031000 USD
jazz Decrease In Liability Under Government Settlement
DecreaseInLiabilityUnderGovernmentSettlement
0 USD
jazz Decrease In Liability Under Government Settlement
DecreaseInLiabilityUnderGovernmentSettlement
-7320000 USD
CY2012Q4 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.78
CY2013Q2 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.87
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
2631000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-3749000 USD
CY2013Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-3749000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
CY2012Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
23702000 USD
CY2012Q2 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
12970000 USD
CY2013Q2 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
19399000 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
38954000 USD
CY2012Q4 jazz Inventory Reclassification
InventoryReclassification
4200000 USD
CY2013Q2 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2012Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2013Q2 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
CY2012Q4 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
CY2013Q2 jazz Parents Company Shareholders Equity
ParentsCompanyShareholdersEquity
1600000000 USD
jazz Payments To Acquire Product Rights
PaymentsToAcquireProductRights
9500000 USD
jazz Payments To Acquire Product Rights
PaymentsToAcquireProductRights
0 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
15463000 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
18573000 USD
CY2013Q1 jazz Proceeds From Secondary Offering
ProceedsFromSecondaryOffering
314400000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1236000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
17000 USD
CY2012Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
1229000 USD
CY2013Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
1688000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
3273000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
2307000 USD
CY2013Q2 jazz Sales Return Reserve
SalesReturnReserve
24039000 USD
CY2012Q4 jazz Sales Return Reserve
SalesReturnReserve
26385000 USD
CY2013Q1 jazz Shares Sold In Secondary Offering
SharesSoldInSecondaryOffering
5400000 shares
jazz Write Offof Deferred Unamortized Debt Costs
WriteOffofDeferredUnamortizedDebtCosts
2700000 USD
CY2013Q2 jazz Write Offof Deferred Unamortized Debt Costs
WriteOffofDeferredUnamortizedDebtCosts
2700000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58153546 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
dei Trading Symbol
TradingSymbol
JAZZ

Files In Submission

Name View Source Status
0001232524-13-000059-index-headers.html Edgar Link pending
0001232524-13-000059-index.html Edgar Link pending
0001232524-13-000059.txt Edgar Link pending
0001232524-13-000059-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
jazz-20130630.xml Edgar Link completed
jazz-20130630.xsd Edgar Link pending
jazz-20130630_cal.xml Edgar Link unprocessable
jazz-20130630_def.xml Edgar Link unprocessable
jazz-20130630_lab.xml Edgar Link unprocessable
jazz-20130630_pre.xml Edgar Link unprocessable
jazz2013q2doc.htm Edgar Link pending
jazzq22013ex311.htm Edgar Link pending
jazzq22013ex312.htm Edgar Link pending
jazzq22013ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R63.htm Edgar Link pending
R63.xml Edgar Link unprocessable
R64.htm Edgar Link pending
R64.xml Edgar Link unprocessable
R65.htm Edgar Link pending
R65.xml Edgar Link unprocessable
R66.htm Edgar Link pending
R66.xml Edgar Link unprocessable
R67.htm Edgar Link pending
R67.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending